Evidence map›Paper›PMID 36449454›Full record

ArticlePloS one2022

COVID-19 associated changes in HIV service delivery over time in Central Africa: Results from facility surveys during the first and second waves of the pandemic.

Ajeh Rogers, Ellen Brazier, Anastase Dzudie, Adebola Adedimeji, Marcel Yotebieng, Benjamin Muhoza, Christella Twizere, Patricia Lelo, Dominique Nsonde, Adolphe Mafoua and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Ajeh RogersClinical Research Education Networking and Consultancy, Yaoundé, Cameroon.ORCID 0000-0002-5361-5063
Ellen BrazierInstitute for Implementation Science in Population Health (ISPH), Graduate School of Public Health and Health Policy, City University of New York, New York, NY, United States of America.
Anastase DzudieClinical Research Education Networking and Consultancy, Yaoundé, Cameroon.
Adebola AdedimejiAlbert Einstein College of Medicine, Bronx, NY, United States of America.
Marcel YotebiengAlbert Einstein College of Medicine, Bronx, NY, United States of America.
Benjamin MuhozaEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Christella TwizereCentre National de Reference en Matière de VIH/SIDA (CNR), Bujumbura, Burundi.
Patricia LeloKalembelembe Pediatric Hospital, Kinshasa, Democratic Republic of Congo.
Dominique NsondeCentre de Traitement Ambulatoire de Brazzaville, Brazzaville, Republic of Congo.
Adolphe MafouaCentre de Traitement Ambulatoire de Pointe Noire, Pointe Noire, Republic of Congo.
Athanase MunyanezaEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Patrick GateretseCentre National de Reference en Matière de VIH/SIDA (CNR), Bujumbura, Burundi.
Merlin DiafoukaCentre de Traitement Ambulatoire de Brazzaville, Brazzaville, Republic of Congo.
Gad MurenziEinstein-Rwanda Research and Capacity Building Program, Rwanda Military Hospital, Kigali, Rwanda.
Théodore NiyongaboCentre National de Reference en Matière de VIH/SIDA (CNR), Bujumbura, Burundi.
Kathryn AnastosAlbert Einstein College of Medicine, Bronx, NY, United States of America.
Denis NashInstitute for Implementation Science in Population Health (ISPH), Graduate School of Public Health and Health Policy, City University of New York, New York, NY, United States of America.ORCID 0000-0002-3280-5386
Albert Einstein College of Medicine · USRwanda Military Hospital · RWCentre Hospitalier et Universitaire de Brazzaville · CGCity University of New York · USKinshasa General Hospital · CDUniversité Professionnelle d'Afrique · CG

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
NIAID NIH HHS U01 AI096299
6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has impacted population health around the globe, directly and indirectly. The objective of this study was to document changes in HIV care associated with the COVID-19 pandemic at selected clinics in Central Africa, along with clinic-level strategies for minimizing disruptions in HIV care and treatment for people with HIV (PWH).

methodsA 51-item questionnaire on COVID-19 pandemic-associated changes in HIV service delivery was completed by clinicians involved in HIV care at 21 clinics in five countries participating in Central Africa International epidemiology Databases to Evaluate AIDS (CA-IeDEA). The survey was completed at two timepoints: June-July 2020 and October 2020 to February 2021. Descriptive statistics were used to characterize changes in HIV care and related services.

resultsWhile 81% of sites reported at least one negative consequence of COVID-19 for clinic operations during the first survey, none reported suspending antiretroviral therapy (ART) initiation services for new patients, and 24% reported adopting telemedicine. In the follow-up survey, fewer sites (48%) reported at least one disruption to clinic operations, and more sites reported mitigation strategies, including expanding rapid ART initiation services and providing extra supplies of ART medications to reduce visit frequency. In the follow-up survey, more sites, especially in Rwanda, reported stockouts of commodities, including HIV and viral load testing and HIV pre-exposure prophylaxis. More than one-fifth of sites reported stockouts of second- or third-line ART at each survey timepoint.

conclusionsWhile the initial wave of the COVID-19 pandemic resulted in concerning disruptions to HIV service delivery at CA-IeDEA sites, most of these disruptions attenuated over time, and many sites introduced measures to help PWH avoid frequent visits to the clinic for care and medications. The impact of HIV commodity stockouts and clinic mitigation strategies on treatment outcomes needs to be assessed.

Indexed as

COVID-19HIV InfectionsAmbulatory Care FacilitiesAnti-Retroviral AgentsHumansPandemicsSurveys and QuestionnairesAnti-Retroviral Agents

Identifiers

PMID36449454
PMCPMC9710788
OpenAlexW4310434626

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.